J. Colombel And M. TÖRÜNER, "Increased risk of morbidity associated with immunomodulatory treatment in patients with inflammatory bowel diseases," Falk Symposium 153 on Immunoregulation in Inflammatory Bowel Diseases , vol.153, Berlin, Germany, pp.85-98, 2006
Colombel, J. And TÖRÜNER, M. 2006. Increased risk of morbidity associated with immunomodulatory treatment in patients with inflammatory bowel diseases. Falk Symposium 153 on Immunoregulation in Inflammatory Bowel Diseases , (Berlin, Germany), 85-98.
Colombel, J., & TÖRÜNER, M., (2006). Increased risk of morbidity associated with immunomodulatory treatment in patients with inflammatory bowel diseases . Falk Symposium 153 on Immunoregulation in Inflammatory Bowel Diseases (pp.85-98). Berlin, Germany
Colombel, J.-F., And MURAT TÖRÜNER. "Increased risk of morbidity associated with immunomodulatory treatment in patients with inflammatory bowel diseases," Falk Symposium 153 on Immunoregulation in Inflammatory Bowel Diseases, Berlin, Germany, 2006
Colombel, J.-F. And TÖRÜNER, MURAT. "Increased risk of morbidity associated with immunomodulatory treatment in patients with inflammatory bowel diseases." Falk Symposium 153 on Immunoregulation in Inflammatory Bowel Diseases , Berlin, Germany, pp.85-98, 2006
Colombel, J. And TÖRÜNER, M. (2006) . "Increased risk of morbidity associated with immunomodulatory treatment in patients with inflammatory bowel diseases." Falk Symposium 153 on Immunoregulation in Inflammatory Bowel Diseases , Berlin, Germany, pp.85-98.
@conferencepaper{conferencepaper, author={J.-F. Colombel And author={MURAT TÖRÜNER}, title={Increased risk of morbidity associated with immunomodulatory treatment in patients with inflammatory bowel diseases}, congress name={Falk Symposium 153 on Immunoregulation in Inflammatory Bowel Diseases}, city={Berlin}, country={Germany}, year={2006}, pages={85-98} }